header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

USE OF CELL SAVER IN INSTRUMENTED THORACO-LUMBAR SPINAL FUSION SURGERY: SHOULD WE USE IT ROUTINELY?



Abstract

Very few reports exist regarding use of intra-operative autologenous transfusion in adult spinal fusion surgery. Specific indications for use of cell saver in thoraco-lumbar spinal instrumentation are not clearly determined. Our objective was to identify the clinical factors associated with increased risk of intra-operative blood loss. To analyse the safety and benefits of using cell saver and to determine the cost-effectiveness.

51 consecutive thoraco-lumbar instrumented fusion over 14 months reviewed. There was no randomisation. Cell saver group consisted of 25 patients and control group consisted of 26 cases. Patients with degenerative scoliosis and tumours excluded. Clinical notes were reviewed.

Demographic data were comparable between the two groups. Iliac crest bone graft harvested in 20% of cell saver group and 40% in control group. Levels of fusion ranged from 1–7 (Mean=2.8) in the cell saver group and 1–4 (Mean=1.9) in the control group. Mean duration of surgery was 15 minutes longer in study group. Intra-operative blood loss was higher in cell saver group (mean=1245 mls vs 800 mls). Significant indicators for duration of surgery were number of levels fused (p< 0.0001), patient weight (p=0.003) and revision surgery (p=0.029). Significant indicators for predicting blood loss were number of levels fused (p< 0.001) and duration of surgery (p=0.0304). 20% in study group (8 units of red cells) and 26% in control group (17 units of red cells) required blood transfusion. Percentage drop in the post-operative haematocrit was 19.1 in study group compared to 36.3 in control group.

In conclusion, 44.38% blood salvaged (35–38% in spinal literature). Use of cell saver significantly decreased post-operative need for blood transfusion. Number of levels of fusion, duration greater than 4 hrs and a low pre-op Haemoglobin/Haematocrit were significant parameters in predicting intra-operative blood loss. If blood loss is less than 700 mls, gains from cell saver are debatable.

Correspondence should be addressed to Editorial Secretary Mr ML Costa or Assistant Editorial Secretary Mr B.J. Ollivere at BOA, 35–43 Lincoln’s Inn Fields, London WC2A 3PE, England; Email: mattcosta@hotmail.com or ben@ollivere.co.uk